View in EDS

Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.

Saved in:
Bibliographic Details
Title: Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.
Authors: Zimmer JA; Eli Lilly and Company, Indianapolis, IN, USA., Sims JR; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: sims_john_r@lilly.com., Evans CD; Eli Lilly and Company, Indianapolis, IN, USA., Nery ESM; Eli Lilly and Company, Indianapolis, IN, USA., Wang H; Eli Lilly and Company, Indianapolis, IN, USA., Wessels AM; Eli Lilly and Company, Indianapolis, IN, USA., Tronchin G; Eli Lilly and Company, Indianapolis, IN, USA., Sato S; Eli Lilly and Company, Indianapolis, IN, USA., Raket LL; Eli Lilly and Company, Indianapolis, IN, USA., Andersen SW; Eli Lilly and Company, Indianapolis, IN, USA., Sapin C; Eli Lilly and Company, Indianapolis, IN, USA., Paget MA; Eli Lilly and Company, Indianapolis, IN, USA., Gueorguieva I; Eli Lilly and Company, Indianapolis, IN, USA., Ardayfio P; Eli Lilly and Company, Indianapolis, IN, USA., Khanna R; Eli Lilly and Company, Indianapolis, IN, USA., Brooks DA; Eli Lilly and Company, Indianapolis, IN, USA., Matthews BR; Eli Lilly and Company, Indianapolis, IN, USA., Mintun MA; Eli Lilly and Company, Indianapolis, IN, USA.
Corporate Authors: Alzheimer’s Disease Neuroimaging Initiative; Eli Lilly and Company, Indianapolis, IN, USA.
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2026 Feb; Vol. 13 (2), pp. 100446. Date of Electronic Publication: 2025 Dec 01.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41330788
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zimmer+JA%22">Zimmer JA</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sims+JR%22">Sims JR</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: sims_john_r@lilly.com.<br /><searchLink fieldCode="AU" term="%22Evans+CD%22">Evans CD</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Nery+ESM%22">Nery ESM</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Wessels+AM%22">Wessels AM</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Tronchin+G%22">Tronchin G</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sato+S%22">Sato S</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Raket+LL%22">Raket LL</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Andersen+SW%22">Andersen SW</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sapin+C%22">Sapin C</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Paget+MA%22">Paget MA</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Gueorguieva+I%22">Gueorguieva I</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Ardayfio+P%22">Ardayfio P</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Khanna+R%22">Khanna R</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+DA%22">Brooks DA</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+BR%22">Matthews BR</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Mintun+MA%22">Mintun MA</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Alzheimer%27s+Disease+Neuroimaging+Initiative%22">Alzheimer’s Disease Neuroimaging Initiative</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101638820%22">The journal of prevention of Alzheimer's disease</searchLink> [J Prev Alzheimers Dis] 2026 Feb; Vol. 13 (2), pp. 100446. <i>Date of Electronic Publication: </i>2025 Dec 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101638820 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2426-0266 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222745807%22">22745807 </searchLink><i>NLM ISO Abbreviation: </i>J Prev Alzheimers Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41330788
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.tjpad.2025.100446
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100446
    Titles:
      – TitleFull: Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zimmer JA
      – PersonEntity:
          Name:
            NameFull: Sims JR
      – PersonEntity:
          Name:
            NameFull: Evans CD
      – PersonEntity:
          Name:
            NameFull: Nery ESM
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Wessels AM
      – PersonEntity:
          Name:
            NameFull: Tronchin G
      – PersonEntity:
          Name:
            NameFull: Sato S
      – PersonEntity:
          Name:
            NameFull: Raket LL
      – PersonEntity:
          Name:
            NameFull: Andersen SW
      – PersonEntity:
          Name:
            NameFull: Sapin C
      – PersonEntity:
          Name:
            NameFull: Paget MA
      – PersonEntity:
          Name:
            NameFull: Gueorguieva I
      – PersonEntity:
          Name:
            NameFull: Ardayfio P
      – PersonEntity:
          Name:
            NameFull: Khanna R
      – PersonEntity:
          Name:
            NameFull: Brooks DA
      – PersonEntity:
          Name:
            NameFull: Matthews BR
      – PersonEntity:
          Name:
            NameFull: Mintun MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2426-0266
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The journal of prevention of Alzheimer's disease
              Type: main
ResultId 1